Drug Database
Back to search

Switzerland· 55041001

Paragol N, Emulsion zum Einnehmen

A liquid paraffin product, registered in Switzerland by Streuli Pharma AG and dispensed under Swissmedic category D. The same ATC class is registered in 8 of our 19 countries.

Cat D (Swissmedic)ATC A06AA01

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedParagol N, Emulsion zum EinnehmenATCA06AA01REGISTER NO.55041001PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ParagolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Liquid paraffin is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AA01 (liquid paraffin), each read from that country’s own register.

  • This record: Switzerland
  • 4 of them publish a price we can compare per daily dose
Search liquid paraffin products by name

Liquid paraffin · ATC A06AA01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Streuli Pharma AG
Country
Switzerland (CH)
ATC code
A06AA01
ATC class
Liquid paraffin
Defined daily dose
15 g, O
Swissmedic category
D
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

256 interactions on record for liquid paraffin.

Graded by severity as the source publishes them — 254 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check liquid paraffin against other medicinesHow interaction checks work

Liquid paraffin · interactions on record

256 records

  • 254 moderate
  • 2 minor

Most severe, free to view

  • CisaprideA03FA02moderate
  • OndansetronA04AA01moderate
  • GranisetronA04AA02moderate
  • DolasetronA04AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A06AA01

Liquid paraffin, as other registers publish it.

All liquid paraffin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b806cae8-9014-4071-849e-cea3f81a407b
GET /v1/drugs/b806cae8-9014-4071-849e-cea3f81a407b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about liquid paraffin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console